Priority Date: 08.09.11 (US 201161532148P)

NOVEL RISK BIOMARKERS FOR LUNG CANCER

  • Application ID: EP12830701
  • Status: The patent has been granted

Applicant

Company dna yeda research and development co ltd
Technology Transfer Office

Attorneys

Employment test 51 - 200 employees
Company dna dennemeyer
operating since 1962
1191.4
Headquarter in Howald and 13 offices
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service
Employment test 201 - 500 employees
Company dna nlo
operating since 1888
Headquarter in The Hague and 3 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G01 (MEASURING; TESTING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Weidner Stern Jeschke, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd and 99 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 08.09.2011 - Priority Date (US 201161532148P)
  • 14.03.2013 - Publication A1 (WO2013035071)
  • 16.07.2014 - Publication A1 (EP2753716)
  • 01.11.2017 - Publication B1 (EP2753716)